liraglutide

Generic: liraglutide

Labeler: hybio pharmaceutical co., ltd. (pingshan factory)
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name liraglutide
Generic Name liraglutide
Labeler hybio pharmaceutical co., ltd. (pingshan factory)
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

liraglutide 18 mg/3mL

Manufacturer
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)

Identifiers & Regulatory

Product NDC 14403-3400
Product ID 14403-3400_2854c47e-c069-07d7-e063-6394a90a50eb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215503
Listing Expiration 2026-12-31
Marketing Start 2024-12-24

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 144033400
Hyphenated Format 14403-3400

Supplemental Identifiers

RxCUI
897122
UNII
839I73S42A
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name liraglutide (source: ndc)
Generic Name liraglutide (source: ndc)
Application Number ANDA215503 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 18 mg/3mL
source: ndc
Packaging
  • 2 SYRINGE, PLASTIC in 1 CARTON (14403-3400-2) / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)
source: ndc

Packages (1)

14403-3400-2 2 SYRINGE, PLASTIC in 1 CARTON (14403-3400-2) / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)

Ingredients (1)

liraglutide (18 mg/3mL)

Linked Drug Pages (3)

Liraglutide ndc-match (0.9) Liraglutide ndc-match (0.9) Liraglutide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "2854c47e-c069-07d7-e063-6394a90a50eb", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "rxcui": ["897122"], "spl_set_id": ["1a372465-d56b-2b80-e063-6394a90a3304"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, PLASTIC in 1 CARTON (14403-3400-2)  / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)", "package_ndc": "14403-3400-2", "marketing_start_date": "20241224"}], "brand_name": "Liraglutide", "product_id": "14403-3400_2854c47e-c069-07d7-e063-6394a90a50eb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "14403-3400", "generic_name": "Liraglutide", "labeler_name": "Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liraglutide", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "18 mg/3mL"}], "application_number": "ANDA215503", "marketing_category": "ANDA", "marketing_start_date": "20241224", "listing_expiration_date": "20261231"}